FDG avidity and PET/CT patterns in primary gastric lymphoma
Lea Radan(Rambam Health Care Campus), Ora Israel(Technion – Israel Institute of Technology), Nissim Haim(Technion – Israel Institute of Technology), Doron Fischer(Rambam Health Care Campus), Eldad J. Dann(Rambam Health Care Campus), Ron Epelbaum(University of Bern), Diana Gaitini(Technion – Israel Institute of Technology), Rachel Bar‐Shalom(Rambam Health Care Campus)
Cited by 82
Related Papers
Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
|Journal of Nuclear Medicine|2009|381
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
|Nutrition and Cancer|2010|279